Vascular endothelial growth factor (VEGF) is a pleiotropic growth factor that is crucially
involved in neurovascular remodeling in the ischemic brain. VEGF promotes angiogenesis …

Neurovascular remodeling has been recently recognized as a promising target for
neurologic therapies. Hopes have emerged that, by stimulating vessel growth, it may be …

Vascular endothelial growth factor (VEGF) is involved in many central nervous system
disorders, including stroke, and confers neuroprotection in cerebral ischemia. In this Mini …

Vascular endothelial growth factor (VEGF) is currently considered a potential pharmacologic
agent for stroke therapy because of its strong neuroprotective and angiogenic capacities …

Vascular endothelial growth factor (VEGF) is an angiogenic protein with therapeutic
potential in ischemic disorders, including stroke. VEGF confers neuroprotection and …

The breakdown of the blood–brain barrier (BBB) is a critical event in the development of
secondary brain injury after stroke. Among the cellular hallmarks in the acute phase after …

Vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1) were originally
identified as endothelial-specific ligands regulating key functions of the vasculature …

Stroke is a major health problem world-wide and its burden has been rising in last few
decades. Until now tissue plasminogen activator is only approved treatment for stroke …

Vascular endothelial growth factor (VEGF) has long been connected to the development of
tissue lesion following ischemic stroke. Contradictory findings either situate VEGF as a …

Ischemic stroke triggers endogenous angiogenic mechanisms, which correlates with longer
survival in patients. As such, promoting angiogenesis appears to be a promising approach …